JP2021524245A5 - - Google Patents

Info

Publication number
JP2021524245A5
JP2021524245A5 JP2020564923A JP2020564923A JP2021524245A5 JP 2021524245 A5 JP2021524245 A5 JP 2021524245A5 JP 2020564923 A JP2020564923 A JP 2020564923A JP 2020564923 A JP2020564923 A JP 2020564923A JP 2021524245 A5 JP2021524245 A5 JP 2021524245A5
Authority
JP
Japan
Prior art keywords
mir
premir
rna
polynucleotide according
premirna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020564923A
Other languages
English (en)
Japanese (ja)
Other versions
JP7545726B2 (ja
JP2021524245A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/033232 external-priority patent/WO2019226603A1/en
Publication of JP2021524245A publication Critical patent/JP2021524245A/ja
Publication of JP2021524245A5 publication Critical patent/JP2021524245A5/ja
Application granted granted Critical
Publication of JP7545726B2 publication Critical patent/JP7545726B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020564923A 2018-05-22 2019-05-21 tRNA/プレmiRNA組成物およびがん治療における使用 Active JP7545726B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862674939P 2018-05-22 2018-05-22
US62/674,939 2018-05-22
PCT/US2019/033232 WO2019226603A1 (en) 2018-05-22 2019-05-21 Trna/pre-mirna compositions and use in treating cancer

Publications (3)

Publication Number Publication Date
JP2021524245A JP2021524245A (ja) 2021-09-13
JP2021524245A5 true JP2021524245A5 (cg-RX-API-DMAC7.html) 2022-05-23
JP7545726B2 JP7545726B2 (ja) 2024-09-05

Family

ID=68616101

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020564923A Active JP7545726B2 (ja) 2018-05-22 2019-05-21 tRNA/プレmiRNA組成物およびがん治療における使用

Country Status (4)

Country Link
US (1) US11946049B2 (cg-RX-API-DMAC7.html)
EP (1) EP3796920A4 (cg-RX-API-DMAC7.html)
JP (1) JP7545726B2 (cg-RX-API-DMAC7.html)
WO (1) WO2019226603A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019204733A1 (en) * 2018-04-20 2019-10-24 The Regents Of The University Of California tRNA/pre-miRNA COMPOSITIONS AND METHODS FOR TREATING HEPATOCELLULAR CARCINOMA
GB201919021D0 (en) 2019-12-20 2020-02-05 Reneuron Ltd Nucleic acid constructs for delivering polynucleotides into exosomes
CN110946872B (zh) * 2019-12-30 2022-11-04 北京大学深圳医院 miR-4491在制备治疗乳腺癌的药物中的应用
BR112022020780A2 (pt) * 2020-04-14 2022-11-29 Flagship Pioneering Innovations Vi Llc Composições de trem e usos das mesmas
CN114058697B (zh) * 2020-07-29 2023-08-18 四川大学华西医院 检测外泌体miR-6774-3p或miR-6776-5p的试剂的用途
WO2022098788A1 (en) * 2020-11-03 2022-05-12 The Regents Of The University Of California Bioengineered wnt5a therapeutics for advanced cancers
US20230416758A1 (en) * 2020-11-23 2023-12-28 Thomas Jefferson University Trna fragments and methods of use
US20240327830A1 (en) * 2022-02-28 2024-10-03 Northwestern University Dise-inducing srna-polyplexes and srna-lipopolyplexes and methods of using the same to treat cancer
IL318039A (en) * 2022-07-10 2025-02-01 Precigen Inc Polycistronic microRNA constructs for immune checkpoint inhibition
CN115323057A (zh) * 2022-09-01 2022-11-11 浙江医院 肺癌治疗疗效相关的生物标志物
CN115896295A (zh) * 2022-12-30 2023-04-04 中国科学技术大学 辅助诊断胆囊炎或预测胆囊炎合并肝损伤的miRNA标志物
CN117126938A (zh) * 2023-10-08 2023-11-28 常州市第一人民医院 一种用于诊断膜性肾病的生物标志物及其应用方法
WO2025155837A1 (en) * 2024-01-19 2025-07-24 Massachusetts Institute Of Technology Modular microrna expression from self-replicating rna (replicons)
CN121406635A (zh) * 2024-05-08 2026-01-27 西安艾领克生物科技有限公司 一种利用活性tRNA在大肠杆菌中嵌合表达重组小RNA的方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2728782T3 (es) * 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
US9340799B2 (en) * 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
JP7026440B2 (ja) * 2014-05-28 2022-02-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ハイブリッドtRNA/プレmiRNA分子および使用方法
WO2016153880A2 (en) 2015-03-23 2016-09-29 The Regents Of The University Of California Methods for detection of rnase activity
WO2019204733A1 (en) 2018-04-20 2019-10-24 The Regents Of The University Of California tRNA/pre-miRNA COMPOSITIONS AND METHODS FOR TREATING HEPATOCELLULAR CARCINOMA

Similar Documents

Publication Publication Date Title
Abba et al. MicroRNAs as novel targets and tools in cancer therapy
Hosseinahli et al. Treating cancer with microRNA replacement therapy: A literature review
JP7026440B2 (ja) ハイブリッドtRNA/プレmiRNA分子および使用方法
Sell et al. MicroRNAs in cancer metastasis: biological and therapeutic implications
Ivkovic et al. microRNAs as cancer therapeutics: A step closer to clinical application
Paladini et al. Targeting microRNAs as key modulators of tumor immune response
Ling et al. MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Li et al. MicroRNAs and drug resistance in prostate cancers
Oom et al. MicroRNAs: novel players in cancer diagnosis and therapies
US20220033815A1 (en) Systemic in vivo delivery of oligonucleotides
Ishida et al. miRNA-based therapeutic strategies
JP7545726B2 (ja) tRNA/プレmiRNA組成物およびがん治療における使用
McDermott et al. The therapeutic potential of microRNAs: disease modulators and drug targets
Iorio et al. Breast cancer and microRNAs: therapeutic impact
Sempere et al. Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer
Xue et al. MicroRNA-targeted therapeutics for lung cancer treatment
Braicu et al. MicroRNAs and cancer therapy–from bystanders to major players
Li et al. MiRNA-based therapeutic strategy in lung cancer
Ciccone et al. The small RNA landscape in NSCLC: current therapeutic applications and progresses
Tan et al. Potential microRNA targets for cancer chemotherapy
Biswas et al. miRNA-based therapeutic strategies
Abubakar et al. Exploring Novel Therapeutic Breakthroughs for Cancers: Potential Roles of miRNAs
A Schmid et al. The role of microRNAs in the pathogenesis and treatment of hematopoietic malignancies
Yu et al. Overcoming drug resistance in colorectal cancer by microRNAs
Aledani et al. MicroRNAs: New non-invasive diagnostic biomarkers and therapeutic method for cancer treatment: MicroRNAs: New non-invasive diagnostic biomarkers and therapeutic method for cancer treatment